Literature DB >> 21071547

A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction.

Douglas S Lee1, Philimon Gona, Irene Albano, Martin G Larson, Emelia J Benjamin, Daniel Levy, William B Kannel, Ramachandran S Vasan.   

Abstract

BACKGROUND: The high mortality rate in patients with heart failure (HF) is influenced by presence of multiple comorbidities. Data are limited on the relative contributions of cardiovascular versus noncardiovascular diseases to death in individuals with HF in the community. METHODS AND
RESULTS: We examined the incidence and predictors of cardiovascular versus noncardiovascular death in participants with HF in the Framingham Heart Study. Underlying, immediate, and contributing causes of death (3 key elements of the World Health Organization classification) were adjudicated by a 3-physician review panel. During 1971 to 2004, 1025 participants with HF died (499 men, mean [SD] age at death 79 [11] years), including 463 participants with left ventricular ejection fraction (LVEF) data. Cardiovascular disease was the cause of death in 66.1% overall. Stratified by LVEF, cardiovascular deaths occurred in 44.5% and 69.9% of those with preserved and reduced LVEF, respectively. Presence of reduced LVEF increased the risk of cardiovascular death, with odds ratios of 3.16 (95% confidence interval [CI], 1.73 to 5.78) in men and 2.39 (95% CI, 1.39 to 4.08) in women. Prior myocardial infarction was associated with increased cardiovascular death in women with HF (odds ratio, 1.87; 95% CI, 1.10 to 3.16) but not in men. The risk of cardiovascular disease death decreased in women (odds ratio after 1980, 0.41; 95% CI, 0.24 to 0.69) and men (odds ratio, 0.66; 95% CI, 0.41 to 1.07, P=0.095) with HF over time. Infections and kidney disease emerged as key immediate and contributing causes of death, respectively.
CONCLUSIONS: Individuals with HF in the community often experience cardiovascular death, but noncardiovascular disease also contributes significantly especially among those with preserved LVEF.

Entities:  

Mesh:

Year:  2010        PMID: 21071547      PMCID: PMC3243964          DOI: 10.1161/CIRCHEARTFAILURE.110.957480

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  30 in total

1.  Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors.

Authors:  E F Philbin; T A Rocco; N W Lindenmuth; K Ulrich; P L Jenkins
Journal:  Am J Med       Date:  2000-12-01       Impact factor: 4.965

2.  Does it matter why and how patients with heart failure die?: a debate that lives on.

Authors:  Paul J Hauptman
Journal:  Circ Heart Fail       Date:  2008-07       Impact factor: 8.790

3.  Mode of death in heart failure: findings from the ATLAS trial.

Authors:  P A Poole-Wilson; B F Uretsky; K Thygesen; J G F Cleland; B M Massie; L Rydén
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

4.  The natural history of congestive heart failure: the Framingham study.

Authors:  P A McKee; W P Castelli; P M McNamara; W B Kannel
Journal:  N Engl J Med       Date:  1971-12-23       Impact factor: 91.245

5.  Some general methods for the analysis of categorical data in longitudinal studies.

Authors:  J R Landis; M E Miller; C S Davis; G G Koch
Journal:  Stat Med       Date:  1988 Jan-Feb       Impact factor: 2.373

6.  Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study.

Authors:  John S Gottdiener; Robyn L McClelland; Robert Marshall; Lynn Shemanski; Curt D Furberg; Dalane W Kitzman; Mary Cushman; Joseph Polak; Julius M Gardin; Bernard J Gersh; Gerard P Aurigemma; Teri A Manolio
Journal:  Ann Intern Med       Date:  2002-10-15       Impact factor: 25.391

7.  The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure.

Authors:  Jeptha P Curtis; Seth I Sokol; Yongfei Wang; Saif S Rathore; Dennis T Ko; Farid Jadbabaie; Edward L Portnay; Stephen J Marshalko; Martha J Radford; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2003-08-20       Impact factor: 24.094

8.  Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis.

Authors:  Douglas S Lee; Lawrence D Green; Peter P Liu; Paul Dorian; David M Newman; F Curry Grant; Jack V Tu; David A Alter
Journal:  J Am Coll Cardiol       Date:  2003-05-07       Impact factor: 24.094

9.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.

Authors:  Salim Yusuf; Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Peter Held; John J V McMurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

10.  Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model.

Authors:  Douglas S Lee; Peter C Austin; Jean L Rouleau; Peter P Liu; David Naimark; Jack V Tu
Journal:  JAMA       Date:  2003-11-19       Impact factor: 56.272

View more
  45 in total

1.  Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction.

Authors:  Sameer Ather; Wenyaw Chan; Biykem Bozkurt; David Aguilar; Kumudha Ramasubbu; Amit A Zachariah; Xander H T Wehrens; Anita Deswal
Journal:  J Am Coll Cardiol       Date:  2012-03-13       Impact factor: 24.094

Review 2.  Use of stem cells in heart failure treatment: where we stand and where we are going.

Authors:  Luis A Sánchez; Carlos Enrique Guerrero-Beltrán; Andrea M Cordero-Reyes; Gerardo García-Rivas; Guillermo Torre-Amione
Journal:  Methodist Debakey Cardiovasc J       Date:  2013 Oct-Dec

Review 3.  Heart failure with preserved ejection fraction in the elderly: scope of the problem.

Authors:  Ken Kaila; Mark J Haykowsky; Richard B Thompson; D Ian Paterson
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

4.  Left ventricle diastolic dysfunction and prognosis.

Authors:  Dalane W Kitzman; William C Little
Journal:  Circulation       Date:  2012-01-18       Impact factor: 29.690

5.  Epidemiology of Left Ventricular Systolic Dysfunction and Heart Failure in the Framingham Study: An Echocardiographic Study Over 3 Decades.

Authors:  Ramachandran S Vasan; Vanessa Xanthakis; Asya Lyass; Charlotte Andersson; Connie Tsao; Susan Cheng; Jayashri Aragam; Emelia J Benjamin; Martin G Larson
Journal:  JACC Cardiovasc Imaging       Date:  2017-10-05

6.  Gender and incidence of dementia in the Framingham Heart Study from mid-adult life.

Authors:  Geneviève Chêne; Alexa Beiser; Rhoda Au; Sarah R Preis; Philip A Wolf; Carole Dufouil; Sudha Seshadri
Journal:  Alzheimers Dement       Date:  2014-01-10       Impact factor: 21.566

7.  Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.

Authors:  Shunichi Homma; John L P Thompson; Min Qian; Siqin Ye; Marco R Di Tullio; Gregory Y H Lip; Douglas L Mann; Ralph L Sacco; Bruce Levin; Patrick M Pullicino; Ronald S Freudenberger; John R Teerlink; Susan Graham; J P Mohr; Arthur J Labovitz; Richard Buchsbaum; Conrado J Estol; Dirk J Lok; Piotr Ponikowski; Stefan D Anker
Journal:  Circ Heart Fail       Date:  2015-04-07       Impact factor: 8.790

8.  Risk factors for rehospitalization in heart failure with preserved ejection fraction compared with reduced ejection fraction.

Authors:  Masahiko Setoguchi; Yuji Hashimoto; Taro Sasaoka; Takashi Ashikaga; Mitsuaki Isobe
Journal:  Heart Vessels       Date:  2014-06-17       Impact factor: 2.037

9.  Heart failure with preserved ejection fraction in African Americans: The ARIC (Atherosclerosis Risk In Communities) study.

Authors:  Deepak K Gupta; Amil M Shah; Davide Castagno; Madoka Takeuchi; Laura R Loehr; Ervin R Fox; Kenneth R Butler; Thomas H Mosley; Dalane W Kitzman; Scott D Solomon
Journal:  JACC Heart Fail       Date:  2013-04       Impact factor: 12.035

Review 10.  Pathological ventricular remodeling: mechanisms: part 1 of 2.

Authors:  Jana S Burchfield; Min Xie; Joseph A Hill
Journal:  Circulation       Date:  2013-07-23       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.